Table 1.
Laboratory findings during first cytomegalovirus infection
| Age | 92D | 97 ~ 99D | 108D | 114D | 121 ~ 122D | 132D | 139D | |
|---|---|---|---|---|---|---|---|---|
| Laboratory | HD Normal | HD 1 | HD 6 ~ 8 | HD 17 | HD 23 | HD 30 ~ 31 | HD 41 | HD 48 |
| WBC | 6000–14 000, µL−1 | 2170 | 1680 | 5360 | 2940 | 2540 | 3250 | 3810 |
| ALC | 1500–3000, µL−1 | 940 | 620 | 3230 | 1700 | 1010 | 2130 | 2670 |
| Hb | 10.5–14.0, g dL−1 | 11.6 | 8.8 | 9.9 | 9.9 | 10.4 | 9.0 | 8.7 |
| PLT | 150–400, ×103 µL−1 | 178 | 187 | 327 | 314 | 286 | 296 | 300 |
| CRP | 0–8, mg dL−1 | 0.4 | ‐ | < 0.3 | < 0.3 | < 0.3 | < 0.3 | < 0.3 |
| TB | 0.2–0.8, mg dL−1 | 0.4 | 0.4 | 0.3 | 0.3 | 0.2 | 0.2 | < 0.15 |
| AST | 13–34, IU L−1 | 141 | 892 | 76 | 62 | 95 | 249 | 127 |
| ALT | 5–46, IU L−1 | 192 | 346 | 85 | 60 | 96 | 155 | 122 |
| LDH | 119–247, IU L−1 | ‐ | 2156 | 345 | 259 | 276 | ‐ | ‐ |
| Ferritin | 22–322, ng mL−1 | ‐ | > 16 500 | 1063.6 | 466.2 | 348 | ‐ | ‐ |
| CD3+ | 2284–4776, µL−1 | ‐ | 22 | ‐ | 1183 | ‐ | ‐ | ‐ |
| CD4+ | 1523–3472, µL−1 | ‐ | 9 | ‐ | 19 | 14 | ‐ | ‐ |
| CD8+ | 524–1583, µL−1 | ‐ | 13 | ‐ | 1150 | 744 | ‐ | ‐ |
| CD19+ | 776–2238, µL−1 | ‐ | 557 | ‐ | 502 | 246 | ‐ | ‐ |
| CD56+ | 230–801, µL−1 | ‐ | 31 | ‐ | 7 | 4 | ‐ | ‐ |
| IgG | 176–601, mg dL−1 | ‐ | ‐ | ‐ | ‐ | ‐ | < 18 | ‐ |
| IgA | 4.4–84, mg dL−1 | ‐ | ‐ | ‐ | ‐ | ‐ | < 5 | ‐ |
| IgM | 17–105, mg dL−1 | ‐ | ‐ | ‐ | ‐ | ‐ | < 5 | ‐ |
| sCD25 | 158–623, U mL−1 | ‐ | 5790 | ‐ | ‐ | ‐ | ‐ | ‐ |
| CMV | < 500, copies mL−1 | 60 255 000 | 18 450 | 4880 | 11 900 | < 500 | < 500 | |
WBC, white blood cell; ALC, absolute lymphocyte count; Hb, haemoglobin; PLT, platelet count; CRP, C‐reactive protein; TB, total bilirubin; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; Ig, immunoglobulin; sCD25, soluble interleukin‐2 receptor; CMV, cytomegalovirus; D, day; HD, hospitalisation day.